Detection of the anti-p53 antibody response in malignant and benign pancreatic disease

References

Page 1

	Year	Citations
Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer L.V. Crawford, D. Pim, R.D. Bulbrook International Journal of Cancer Lung MetastasesOncologyBreast OncologyCellular Protein P53Cancer Detection	1982	452
Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer CM Barton, SL Staddon, CM Hughes, British Journal of Cancer Tumor BiologyPancreatic CancerMedicinePathologyHuman Pancreatic Cancer	1991	376
Pancreatic adenocarcinomas frequently show p53 gene mutations. Aldo Scarpa, P. Capelli, Kiyoshi Mukai, PubMed	1993	336
Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation. Stefan Winter, John D. Minna, Bruce E. Johnson, PubMed Tumor BiologyOncologyMedicineP53 AntigenImmunology	1992	303
The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot. Beata Schlichtholz, Yann Legros, Daniel Gillet, PubMed Breast OncologyImmunologyImmunoeditingPathologyImmunotherapy	1992	282
Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers. Andrew M. Davidoff, J. Dirk Iglehart, Jeffrey R. Marks Proceedings of the National Academy of Sciences Breast OncologyImmunologyImmune RegulationPathologyP53 Protein	1992	277
p53 and K-RAS alterations in pancreatic epithelial cell lesions. Holger Kalthoff, Wolff Schmiegel, Christian Roeder, PubMed	1993	185
Human pancreatic carcinomas and cell lines reveal frequent and multiple alterations in the p53 and Rb-1 tumor-suppressor genes. Bruce Ruggeri, S.-Y. Zhang, Jorge Caamaño, PubMed	1992	172
p53 Mutations are common in pancreatic cancer and are absent in chronic pancreatitis Graham Casey, Yoichiro Yamanaka, Michael S. Kobrin, Cancer Letters Tumor BiologyChronic PancreatitisP53 MutationsPancreatic CancerMedicine	1993	169
Analyses of p53 antibodies in sera of patients with lung carcinoma define immunodominant regions in the p53 protein Beata Schlichtholz, Jean Trédaniel, Richard Lubin, British Journal of Cancer MedicineImmunologyPathologyBronchial NeoplasmP53 Protein	1994	143

Page 1